GlobeNewsWire
23 Jun 2026, 21:50 UTC · 13w ago
Verdict
Headline takes no side. We score ADCT −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 94% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
ADC Therapeutics' Phase 3 LOTIS-5 trial for ZYNLONTA reported 27 deaths in the treatment arm compared to nine in the immunotherapy arm.
More negative than 99% of claims this week
Pomerantz LLP is investigating ADC Therapeutics for potential securities fraud or unlawful business practices following the LOTIS-5 data release.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 90% of claims this week
ADC Therapeutics' stock price declined 66.56% over two trading sessions following the announcement of the LOTIS-5 topline data.
So whatThis confirms the market's immediate and severe negative valuation of the drug's clinical profile.
More negative than 76% of claims this week
Which stocks this story touches
More negative than 94% of ticker scores this week
The company is facing a class action investigation into securities fraud following poor trial data and a 66% stock price collapse.
More negative than 83% of ticker scores this week
The company is the subject of a legal investigation by Pomerantz LLP on behalf of investors.
More negative than 83% of ticker scores this week
The company is the subject of a legal investigation by Pomerantz LLP on behalf of investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
2h ago
+9.6%
Price is moving against the score
$1.26 vs $1.15 close before publication (Jun 23) · not market-adjusted
ADCT chart →
